Israel Englander Applied Therapeutics Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 277,370 shares of APLT stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

277,370

Previous 110,908 150.09%

Holding current value

$2.55 Million

Previous $517,000 355.9%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.35 - $8.5 $724,109 - $1.41 Million	166,462 Added 150.09%	277,370 $2.36 Million
Q2 2024 Aug 14, 2024	SELL	$4.04 - $6.37 $3.29 Million - $5.19 Million	-815,517 Reduced 88.03%	110,908 $517,000
Q1 2024 May 15, 2024	BUY	$2.25 - $7.4 $734,370 - $2.42 Million	326,387 Added 54.39%	926,425 $6.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $1.02 Million - $1.85 Million	552,278 Added 1156.36%	600,038 $2.01 Million
Q2 2023 Aug 14, 2023	SELL	$0.77 - $1.8 $103,230 - $241,318	-134,066 Reduced 73.73%	47,760 $61,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.21 $89,912 - $145,058	119,883 Added 193.54%	181,826 $147,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $1.12 $20,270 - $42,042	-37,538 Reduced 37.73%	61,943 $47,000
Q3 2022 Nov 14, 2022	SELL	$0.86 - $1.55 $224,746 - $405,066	-261,333 Reduced 72.43%	99,481 $93,000
Q2 2022 Aug 15, 2022	BUY	$0.76 - $2.64 $192,065 - $667,175	252,718 Added 233.79%	360,814 $342,000
Q1 2022 May 16, 2022	BUY	$1.48 - $6.22 $55,847 - $234,711	37,735 Added 53.63%	108,096 $228,000
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $512,413 - $1.07 Million	58,428 Added 489.63%	70,361 $630,000
Q3 2021 Nov 15, 2021	BUY	$13.54 - $22.06 $161,572 - $263,241	11,933 New	11,933 $198,000
Q2 2021 Aug 16, 2021	SELL	$14.05 - $25.04 $271,642 - $484,123	-19,334 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.57 - $28.65 $1.06 Million - $1.83 Million	-63,959 Reduced 76.79%	19,334 $363,000
Q4 2020 Feb 16, 2021	BUY	$15.44 - $24.23 $781,696 - $1.23 Million	50,628 Added 154.99%	83,293 $1.83 Million
Q3 2020 Nov 16, 2020	BUY	$19.43 - $35.36 $367,304 - $668,445	18,904 Added 137.37%	32,665 $678,000
Q2 2020 Aug 14, 2020	SELL	$29.41 - $51.23 $2.22 Million - $3.87 Million	-75,563 Reduced 84.59%	13,761 $497,000
Q1 2020 May 14, 2020	BUY	$19.54 - $55.47 $1.75 Million - $4.95 Million	89,324 New	89,324 $2.92 Million
Q4 2019 Feb 14, 2020	SELL	$10.16 - $28.14 $267,106 - $739,800	-26,290 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.08 - $10.99 $241,955 - $329,095	-29,945 Reduced 53.25%	26,290 $288,000
Q2 2019 Aug 14, 2019	BUY	$8.1 - $10.05 $455,503 - $565,161	56,235 New	56,235 $463,000

Others Institutions Holding APLT

# of Institutions

140

Shares Held

112M

Call Options Held

1.68M

Put Options Held

1.91M

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $442M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account